180 related articles for article (PubMed ID: 21721599)
1. Variation over time in the association between polypharmacy and mortality in the older population.
Richardson K; Ananou A; Lafortune L; Brayne C; Matthews FE
Drugs Aging; 2011 Jul; 28(7):547-60. PubMed ID: 21721599
[TBL] [Abstract][Full Text] [Related]
2. Self-reported medication use for older people in England and Wales.
Chen YF; Dewey ME; Avery AJ;
J Clin Pharm Ther; 2001 Apr; 26(2):129-40. PubMed ID: 11350536
[TBL] [Abstract][Full Text] [Related]
3. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
Porter B; Arthur A; Savva GM
BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
[TBL] [Abstract][Full Text] [Related]
4. Multimorbidity and Polypharmacy Are Independently Associated With Mortality in Older People With Intellectual Disabilities: A 5-Year Follow-Up From the HA-ID Study.
Schoufour JD; Oppewal A; van der Maarl HJK; Hermans H; Evenhuis HM; Hilgenkamp TIM; Festen DA
Am J Intellect Dev Disabil; 2018 Jan; 123(1):72-82. PubMed ID: 29281324
[TBL] [Abstract][Full Text] [Related]
5. Frailty, Polypharmacy, and Health Outcomes in Older Adults: The Frailty and Dependence in Albacete Study.
Bonaga B; Sánchez-Jurado PM; Martínez-Reig M; Ariza G; Rodríguez-Mañas L; Gnjidic D; Salvador T; Abizanda P
J Am Med Dir Assoc; 2018 Jan; 19(1):46-52. PubMed ID: 28899661
[TBL] [Abstract][Full Text] [Related]
6. Polypharmacy status as an indicator of mortality in an elderly population.
Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
Drugs Aging; 2009; 26(12):1039-48. PubMed ID: 19929031
[TBL] [Abstract][Full Text] [Related]
7. Medication Regimen Complexity and Polypharmacy as Factors Associated With All-Cause Mortality in Older People: A Population-Based Cohort Study.
Wimmer BC; Bell JS; Fastbom J; Wiese MD; Johnell K
Ann Pharmacother; 2016 Feb; 50(2):89-95. PubMed ID: 26681444
[TBL] [Abstract][Full Text] [Related]
8. Survival of the elderly and exposition to polypharmacy in the city of São Paulo, Brazil: SABE Study.
Romano-Lieber NS; Corona LP; Marques LFG; Secoli SR
Rev Bras Epidemiol; 2019 Feb; 21Suppl 02(Suppl 02):e180006. PubMed ID: 30726351
[TBL] [Abstract][Full Text] [Related]
9. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy.
Lapi F; Pozzi C; Mazzaglia G; Ungar A; Fumagalli S; Marchionni N; Geppetti P; Mugelli A; Di Bari M
Drugs Aging; 2009; 26(12):1029-38. PubMed ID: 19929030
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
12. Medication prescription among elderly patients admitted through an acute assessment unit.
Yong TY; Lau SY; Li JY; Hakendorf P; Thompson CH
Geriatr Gerontol Int; 2012 Jan; 12(1):93-101. PubMed ID: 21929721
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of polypharmacy among older primary care patients in Germany.
Junius-Walker U; Theile G; Hummers-Pradier E
Fam Pract; 2007 Feb; 24(1):14-9. PubMed ID: 17164234
[TBL] [Abstract][Full Text] [Related]
14. Medications for Chronic Conditions and Mortality in Older Adults.
Hsu HF; Tu HP; Chen KM; Belcastro F
Nurs Res; 2023 Jan-Feb 01; 72(1):30-37. PubMed ID: 36053079
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy, Gait Performance, and Falls in Community-Dwelling Older Adults. Results from the Gait and Brain Study.
Montero-Odasso M; Sarquis-Adamson Y; Song HY; Bray NW; Pieruccini-Faria F; Speechley M
J Am Geriatr Soc; 2019 Jun; 67(6):1182-1188. PubMed ID: 30698285
[TBL] [Abstract][Full Text] [Related]
17. High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality.
Woudstra OI; Kuijpers JM; Meijboom FJ; Post MC; Jongbloed MRM; Duijnhouwer AL; van Dijk APJ; van Melle JP; Konings TC; Zwinderman AH; Mulder BJM; Bouma BJ
Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):216-225. PubMed ID: 30903133
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy and patterns of prescription medication use among cancer survivors.
Murphy CC; Fullington HM; Alvarez CA; Betts AC; Lee SJC; Haggstrom DA; Halm EA
Cancer; 2018 Jul; 124(13):2850-2857. PubMed ID: 29645083
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacy is differentially associated with 20-year mortality among community-dwelling elderly women and men: The Israel Glucose Intolerance, Obesity and Hypertension cohort study.
Orenstein L; Chetrit A; Goldman A; Novikov I; Dankner R
Mech Ageing Dev; 2023 Apr; 211():111788. PubMed ID: 36758642
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80+: A Five-Year Follow-Up Study.
Wang R; Chen L; Fan L; Gao D; Liang Z; He J; Gong W; Gao L
PLoS One; 2015; 10(11):e0142123. PubMed ID: 26554710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
